Cytokinetics, Incorporated (CYTK) Rises: Stock Jumps 12.6% – Tale of the Tape
Cytokinetics, Incorporated ( CYTK ) was a big mover last session, as the company saw its shares rise more than 12% on the day. The rise came as the company announced the expansion of its existing collaboration with Astellas Pharma Inc. to facilitate the development of CK-2127107, a fast skeletal troponin activator, in Spinal Muscular Atrophy (SMA), which led to more shares changing hands than in a normal session […]